Biopharma PEG Expands Multi-Arm PEG Product Line
Watertown, MA, 2024-Aug-24 — /EPR Network/ — Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG [read full press release…]
Articles by sunnyfang1419
Biopharma PEG Launches New Monodispersed PEGs for Better Drug Delivery
Watertown, MA, 2024-Jul-24 — /EPR Network/ — Biopharma PEG, a top supplier of PEG derivatives, is excited to introduce its new line of monodispersed PEGs. [read full press release…]
Biopharma PEG to Exhibit at BIO 2024 in San Diego
Watertown, MA, 2024-Jul-01 — /EPR Network/ — Biopharma PEG, a leading provider of advanced polyethylene glycol (PEG) derivatives, is excited to announce its participation in [read full press release…]
Visit Biopharma PEG Scientific Inc. at PEGS Boston Summit and TIDES USA 2024
Watertown, United States, 2024-Mar-31 — /EPR Network/ — Biopharma PEG Scientific Inc., a pioneering biotechnology company based in Watertown, Massachusetts, is set to make a [read full press release…]
Biopharma PEG’s Azide PEG Series for Pharmaceuticals
Watertown, MA, 2024-Jan-21 — /EPR Network/ — Biopharma PEG, a leading innovator in polyethylene glycol (PEG) derivatives, proudly introduces its featured Azide PEG series, which [read full press release…]
Biopharma PEG Assists ADC Development with Monodispersed PEGs
Watertown, MA, 2023-Nov-19 — /EPR Network/ — Biopharma PEG, a leading name in the pharmaceutical industry, is proud to announce a groundbreaking advancement in the [read full press release…]
Biopharma PEG: Your Premier Source for High-Purity Monodispersed PEGs
Watertown, MA, 2023-Oct-21 — /EPR Network/ — Biopharma PEG, a leading provider of innovative solutions for the pharmaceutical industry, is proud to announce an extensive [read full press release…]
Biopharma PEG Supplies Cholesterol (Plant-Derived) Used As Excipients for Lipid Nanoparticles (LNPs)
Watertown, MA, 2023-Aug-21 — /EPR Network/ — Cholesterol, a derivative of cyclopentane polyhydrophenanthrene, is the main steroid compound in mammals. Most of the traditional cholesterol [read full press release…]
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
Watertown, MA, 2023-Jul-15 — /EPR Network/ — What is “click chemistry”? “Click Chemistry”, this is a literary name given to this kind of reaction by [read full press release…]
Optimization of Three Elements of ADC Drugs
Watertown, MA, 2023-Jul-03 — /EPR Network/ —Structurally, an ADC consists of monoclonal antibodies (Antibody) that target specific antigens on tumor surfaces, cytotoxic drugs (drugs) that kill tumor cells, and linkers (Conjugate/ linkers) that conjugate cytotoxic drugs to antibodies. The link between the antibody and linker is controlled by the coupling method, which determines the DAR value of the drug and affects the stability and PK characteristics of the ADC. The connection of Linker to the drug is controlled by a shearable/non-shearable technique that determines the properties of the active payload, the rate at which the payload is released, and affects the solubility, stability, and titer of the ADC. Optimization of Antibody: Development of new targets and dual antibody ADCs The selection of antibodies [read full press release…]
ADC Drugs For Breast Cancer Treatment
Watertown, MA, 2023-Mar-29 — /EPR Network/ — Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the [read full press release…]
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Watertown, MA, 2023-Jan-29 — /EPR Network/ — Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody [read full press release…]
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Watertown, MA, 2022-Nov-29 — /EPR Network/ — Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into [read full press release…]
Huateng Pharma Develops Intermediates of Carfilzomib For Multiple Myeloma
Hunan Province, China, 2022-Nov-29 — /EPR Network/ — Carfilzomib, a proteasome inhibitor, is indicated for the treatment of patients with multiple myeloma. Multiple myeloma [read full press release…]
ADC Targets And Representative Drugs For Non-Small Cell Lung Cancer (NSCLC)
Watertown, MA, 2022-Oct-26 — /EPR Network/ — Technological advances have re-established ADC as a viable treatment strategy for advanced solid tumors. ADCs targeting several tumor [read full press release…]
Development History of ADC Drugs
Watertown, MA, 2022-Oct-26 — /EPR Network/ — Antibody-drug conjugate (ADC) consists of linker, payload, and monoclonal antibody (mAb). It combines the advantages of high specific [read full press release…]
New Technology of PROTACs
Watertown, MA, 2022-Jul-30 — /EPR Network/ — Most of the drugs currently in clinical use are based on small molecules and use the “occupancy-driven” mode [read full press release…]
Nanoparticle-based COVID-19 vaccine for future infectious diseases
Watertown, MA, 2022-Mar-29 — /EPR Network/ — Just one dose of a new nanoparticle-based COVID-19 vaccine is enough to generate an immune response in animals, and the [read full press release…]
Semaglutide VS Liraglutide: Which Is Better For Weight Loss
Arlington, VA, 2022-Feb-27 — /EPR Network/ — Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in [read full press release…]
What’re The Applications of 3D Printing in Drug Delivery
Watertown, MA, 2022-Jan-25 — /EPR Network/ — 3D printing (3DP) technology has been repurposed to apply to pharmaceutical development, in recent years it has been [read full press release…]
